- In June 2022, Avid Bioservices, Inc. opened its analytical and process development (AD/PD) suites. These suites were part of the company's lentiviral vector development and Current Good Manufacturing Plant (CGMP) manufacturing facility
- In May 2022, AGC Biologics said that it would add viral vector suspension technology and space to its commercial-grade site in Longmont, Colorado. This would make it easier to study and make gene therapies
